nanotech investing Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
nanotech investing Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors
nanotech investing Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers
nanotech investing Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
nanotech investing Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress
Transition Metals Expands Gowganda Gold Project to 65 Kilometres-Squared, Commences Summer Exploration Program, and Confirms DTC Eligibility
Gold Runner Exploration Announces Mobilization Date and Exploration Program Update at Golden Girl Property, Golden Triangle B.C.
QIMC Reports 10.77% Hydrogen Mud-Gas Reading at West-Advocate - Five Stacked %-Level Readings in a 69-Metre Methane-Free Hydrogen-Rich Interval in Hole DDH-26-03, West Advocate, Nova Scotia
Torrent Capital Reports Q1 2026 Financial Results; Provides Preliminary April Net Asset Value and Portfolio Update
